Related references
Note: Only part of the references are listed.Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
Jae-Won Hyun et al.
ONCOTARGET (2017)
Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
Zhen Zhang et al.
DISEASE MARKERS (2017)
Leptomeningeal metastasis: Clinical experience of 519 cases
Jae-Won Hyun et al.
EUROPEAN JOURNAL OF CANCER (2016)
Central Nervous System Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines
Louis Burt Nabors et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Ventriculolumbar Perfusion Chemotherapy With Methotrexate for Treating Leptomeningeal Carcinomatosis: A Phase II Study
Ho-Shin Gwak et al.
ONCOLOGIST (2014)
Ventriculolumbar Perfusion Chemotherapy for the Treatment of Leptomeningeal Carcinomatosis A Phase I Study With Pharmacokinetic Data
Ho-Shin Gwak et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
S. Boeck et al.
BRITISH JOURNAL OF CANCER (2013)
The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer
Peng Wang et al.
CANCER BIOMARKERS (2013)
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa
A. Comte et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung
Seong Yong Park et al.
LUNG CANCER (2013)
Survival of breast cancer patients with meningeal carcinomatosis
H. Gauthier et al.
ANNALS OF ONCOLOGY (2010)
New Strategies in the Management of Leptomeningeal Metastases
Morris D. Groves
ARCHIVES OF NEUROLOGY (2010)
Electrogenerated Chemiluminescence
Robert J. Forster et al.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY (2009)
Clinical utility of cytokeratins as tumor markers
V Barak et al.
CLINICAL BIOCHEMISTRY (2004)